glp-1 препараты Агонисты рецепторов глюкогоноподобного пептида 1 типа и новые возможности первичной профилактики сердечно-сосудистых осложнений у больных сахарным диабетом 2 типа Судебные иски против главного медицинского
Description
Cancer Chemother
Lessons from clinical trials demonstrate these effects are mainly driven by reductions in albuminuria
In that backdrop, the judicious thing to do was to not over-commit and thats exactly what they did: didnt kill danuglipron, said its alive and may move forward. Pfizer said theyll move the pill to a mid-stage study in the second half of this year
( Epub 2021/04/28 )
